AbbVie Aktie

203,00 EUR +3,00 EUR +1,50 %

16:54:16

FSE

234,03 USD +0,13 USD +0,06 %

21:46:11

BTT

AbbVie jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.353,87 Mrd. EUR

KGV74,34Div. Rendite3,54%

WKNA1J84E

ISINUS00287Y1091

SymbolABBV

AbbVie Aktien News

Sortieren:Datum Meistgelesen

14.01.25ZacksAbbVie Falls 8% in 3 Months: Buy, Hold or Sell the Stock?

14.01.25ZacksAbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

13.01.25BenzingaLike Bristol-Myers Squibb And AbbVie, Johnson & Johnson Seeks To Bolster Neuropsychiatric Portfolio With $15 Billion Deal

13.01.25PR NewswireAbbVie and Simcere Zaiming Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma

13.01.25PR NewswireAbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program

10.01.25BenzingaAbbVie Unusual Options Activity For January 10

09.01.25PR NewswireAbbVie to Present at the 43rd Annual J.P. Morgan Healthcare Conference

08.01.25BenzingaAssessing AbbVie: Insights From 17 Financial Analysts

08.01.25BenzingaHere's How Much $1000 Invested In AbbVie 5 Years Ago Would Be Worth Today

07.01.25ZacksAbbVie (ABBV) Stock Moves -0.32%: What You Should Know

07.01.25ZacksWill AbbVie (ABBV) Beat Estimates Again in Its Next Earnings Report?

07.01.25PR NewswireCoolMonth is Back With Deals on CoolSculpting® Elite by Allergan Aesthetics

07.01.25ZacksAbbVie Cuts 2024 EPS Guidance to Include Acquisition Costs

03.01.25PR NewswireAbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call

03.01.25ZacksThe Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer

31.12.24ZacksAbbVie (ABBV) Gains As Market Dips: What You Should Know

31.12.24ZacksAbbVie (ABBV) Upgraded to Buy: What Does It Mean for the Stock?

31.12.24ZacksBrokers Suggest Investing in AbbVie (ABBV): Read This Before Placing a Bet

31.12.24ZacksAbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It

24.12.24ZacksAbbVie (ABBV) Rises Yet Lags Behind Market: Some Facts Worth Knowing

24.12.24Benzinga$100 Invested In AbbVie 5 Years Ago Would Be Worth This Much Today

23.12.24MotleyFoolIs AbbVie Stock a Buy?

19.12.24PR NewswireAbbVie's atogepant and onabotulinumtoxinA receive strong recommendations in the newly updated Canadian Headache Society (CHS) Migraine Prevention Guideline

18.12.24ZacksInvestors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

16.12.24ZacksAbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors

13.12.24PR NewswireAbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline

11.12.24PR NewswireAbbVie Completes Acquisition of Aliada Therapeutics

10.12.24BenzingaAnalyst Scoreboard: 19 Ratings For AbbVie

10.12.24ZacksThe Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group

09.12.24ZacksTop Stock Reports for Eli Lilly, AbbVie & Gilead Sciences

09.12.24PR NewswireTwo Data Analyses From Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable Complete Reponses As Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma

09.12.24PR NewswireAbbVie Announces Positive Topline Results for the Phase 3 TEMPO-2 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease

08.12.24PR NewswireInvestigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

03.12.24ZacksHere is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock

29.11.24BenzingaSpotlight on AbbVie: Analyzing the Surge in Options Activity

29.11.24ZacksWhy Is AbbVie (ABBV) Down 10.2% Since Last Earnings Report?

25.11.24ZacksAbbVie Stock Rises After Leerink Partners Upgrades Its Rating

25.11.24PR NewswireAbbVie to Present at Citi's 2024 Global Healthcare Conference

20.11.24BenzingaUnpacking the Latest Options Trading Trends in AbbVie

20.11.24ZacksIs Trending Stock AbbVie Inc. (ABBV) a Buy Now?

AbbVie News

AbbVie News: auf dieser Seite finden Sie alle AbbVie News und Nachrichten zur AbbVie Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch AbbVie News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um AbbVie News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.